Our life sciences fund fuels new medical development projects to benefit public health and improve quality of life. We are the unique investment partner to life sciences companies. We provide new means for capital to reach promising life sciences companies and we open access to emerging medical technologies for potential partners seeking tomorrow's therapies and treatments. Prevail Partners focuses on investments in clinical-stage biotech and pharma companies, and is actively pursuing new investments in both public and private companies.